Recently announced results from the phase 2 dosing trial (NCT045243351) of ANVS401 (Annovis Bio) showed that the investigational agent was well-tolerated and was superior to placebo on improving motor function in patients with Parkinson disease (PD).1 A total of 54 patients with PD were recruited in the analysis, an increase from the original cohort which […]

When it comes to addiction treatment, many people believe you need to start a 12-step program and practice complete abstinence. The general belief is that these are the only treatment options and ways to judge success. If you have a relapse and start using again, you’ve failed and need to start over. But is that […]

While CAR-T cell therapies have been a promising new area of cancer treatments, they are costly to produce, have had limited success in treating solid tumors, and can carry sometimes serious side effects. Shoreline Biosciences is developing off-the-shelf natural killer and macrophage cellular immunotherapies derived from induced pluripotent stem cells for cancer, inflammatory, and genetic […]